Top compounds associated with response to CLDN9


Feature Type Standardized
Nominal ANOVA
mRNA FQI-1 CTRPv2 pan-cancer AAC -0.076 0.1
mRNA Doxorubicin CTRPv2 pan-cancer AAC -0.05 0.1
mRNA itraconazole CTRPv2 pan-cancer AAC 0.063 0.1
mRNA foretinib GDSC1000 pan-cancer AAC -0.053 0.1
mRNA BRD-K27188169 CTRPv2 pan-cancer AAC -0.085 0.1
mRNA VX-680 GDSC1000 pan-cancer AAC -0.084 0.1
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.061 0.1
mRNA GW-2580 GDSC1000 pan-cancer AAC -0.056 0.1
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.057 0.1
mRNA CMK GDSC1000 pan-cancer AAC 0.084 0.1
Download CSV